Dr. Sfakianos discusses the relevance of the Gleason grading system as a predictor of outcomes for patients with prostate cancer, as well as risk stratification and novel grouping systems that provide precise grade stratification and that are highly correlated with outcomes.
Related Presenters
Assistant Professor of Urology
Icahn School of Medicine at Mount Sinai
